Introduction: New Directions in the Treatment of Atypical Depression
J Clin Psychiatry 2007;68(suppl 3):4-7
© Copyright 2014 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
In this supplement, each article focuses on a different aspect of atypical depression. First, Jonathan R. T. Davidson, M.D., examines the evolution of the concept of atypical depression; second, Gordon B. Parker, M.D., Ph.D., D.Sc., discusses the validity of the current concept and suggests a new model for viewing atypical depression from a personality spectrum perspective; third, Jonathan W. Stewart, M.D., presents a review of the treatment literature, focusing on established therapies and ending with the work on selective serotonin reuptake inhibitors (SSRIs); and finally, Mark H. Rapaport, M.D., considers newer perspectives on treatment of atypical depression and evaluates recent therapy developments. This brief overview touches on the topics that each author addresses.